LSX2026: Endogenous tissue restoration in vascular disease – Insights from Paulo Neves

R&D
Interview at LSX 2026 with Paulo Neves

In our final video from the LSX World Congress in Lisbon, Portugal, web editor Nicole Raleigh spoke with Paulo Neves, CMO of Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels.

The conversation explores the company’s ambition to improve standards of care for millions of patients who undergo vascular surgery every year, the landscape of unmet need in haemodialysis access and coronary arterial bypass surgery, as well as the current investment appetite and why global intentions matter.

Watch this and our other interviews from on the ground at both LSX 2026 and BIO-Europe Spring here.


Market Access
12 questions with: Daniel Kohlstaedt

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.